Lexeo Therapeutics, Inc. (LXEO) Live Share Price, Invest From India

Lexeo Therapeutics, Inc. Stock Performance

as on October 1, 2026 at 3:10 am IST

Day's Low
Day's High
$3.33
Day's Price Range
$3.59
$3.45
3.48%
Downside
4.06%
Upside
52 Week's Low
52 Week's High
$2.98
52-Week Price Range
$10.99
$3.45
13.62%
Downside
218.55%
Upside

Lexeo Therapeutics, Inc. share price movements today

Previous Close: $3.42
Open: $3.45
Volume: 918.4K
Market Cap: $257.8M
Day's Low - High: $3.33 - $3.59
52 Week Low - High: $2.98 - $10.99

Lexeo Therapeutics, Inc. Historical Returns

1 Month Return: -29.63 %
3 Month Return: -26.53 %
1 Year Return: -48.49 %
3 Year Return: 0 %
5 Year Return: 0 %

Lexeo Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Lexeo Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$257.8M

EPS (TTM)

-1.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.73

Industry PE ratio

-8.70

PEG Ratio

-0.02

EBITDA

-85.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-41.85%

Lexeo Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lexeo Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Lexeo Therapeutics, Inc.	Buy	$257.8M	NA	-2.73	0.00%	0.00%
Revolution Medicines	StrongBuy	$43.2B	643.29%	-22.77	0.00%	0.00%
Moderna	Neutral	$78.8B	-47.13%	-24.72	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$133.4B	189.75%	30.38	86.04%	0.00%
Regeneron	Buy	$81.1B	24.01%	17.96	84.86%	0.49%

Stock Returns calculator for Lexeo Therapeutics, Inc. Stock including INR - Dollar returns

The Lexeo Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Lexeo Therapeutics, Inc. investment value today

Current value as on today

₹56,045

Returns

-₹43,955

(-43.95%)

Returns from Lexeo Therapeutics, Inc. Stock

-₹48,042 (-48.04%)

Dollar Impact

₹4,087 (+4.09%)

Analyst Recommendation on Lexeo Therapeutics, Inc. Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Lexeo Therapeutics, Inc.. Average target price of $20.3

Lexeo Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Lexeo Therapeutics, Inc..

What analysts predicted

83%UPSIDE

Target Price

$20.3

Current Price

$3.45

Analyzed by

2 Analysts

High

$20

Target

$20.30

Low

$17

Lexeo Therapeutics, Inc. target price $20.3, a slight upside of 83% compared to current price of $3.45. According to 2 analysts rating.

Indian Investors' Interest in Lexeo Therapeutics, Inc. Stock

Search interest for Lexeo Therapeutics, Inc. Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 31, 2026 to September 30, 2026

Change:-36% versus previous 30 day period

Lexeo Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	0	-
Operating Income	-23	-23	-31	-27	-33	-30	-21	-23	-22	-28
EBITDA	-21	-20	-28	-25	-32	-25	-19	-20	-19	-25
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-21	-21	-29	-25	-32	-26	-20	-20	-20	-25
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-21	-21	-29	-25	-32	-26	-20	-20	-20	-25
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Lexeo Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	1	0	-	-	-
Gross Profit	0	1	0	-	-	-
Operating Income	-4	-50	-60	-68	-105	-109
EBITDA	-4	-50	-58	-64	-96	-97
Interest Expense	0	-	0	0	0	0
Depreciation	-	0	1	1	2	2
Income Before Tax	-5	-50	-59	-66	-98	-99
Income Tax Expense	-	-	-	-	-	-
Net Income	-5	-50	-59	-66	-98	-99
Net Profit Margin	100.00%	100.00%	100.00%	0.00%	0.00%	0.00%

Lexeo Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-21	-21	-29	-25	-32	-26	-20	-20	-20	-25
Operating Cash Flow	-14	-20	-17	-28	-21	-27	-29	-20	-21	-17
Investing Cash Flow	0	0	0	-93	15	-39	35	-101	27	14
Financing Cash Flow	88	0	0	0	0	72	0	143	2	24
Change in Cash	73	-20	-17	-122	-6	6	5	22	8	21

Lexeo Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-50	-59	-66	-98	-99
Operating Cash Flow	-3	-44	-54	-59	-81	-98
Investing Cash Flow	-	0	0	0	-94	-90
Financing Cash Flow	32	150	0	103	88	216
Change in Cash	29	106	-55	44	-86	27

Global Institutional Holdings in Lexeo Therapeutics, Inc.

Check out the Institutions with significant holdings in Lexeo Therapeutics, Inc..

Funds	Holdings
Peter Kolchinsky	6.09%
Vanguard	4.34%
iShares	4.24%
VANGUARD INDEX FUNDS	3.57%
Michael Rockefeller	3.05%

See all

Insights on Lexeo Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 37.0K → 1.94M (in $), with an average increase of 82.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 736.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -20.19M → -25.86M (in $), with an average decrease of 28.1% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, LXEO stock has moved down by -29.6%

About Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.

Organisation	Lexeo Therapeutics, Inc.
Headquarters	345 Park Avenue South, New York City, NY, 10010, US
Industry	Biotechnology
CEO	R. Nolan Townsend

Key Management of Lexeo Therapeutics, Inc.

Name	Title
Dr. Narinder P. Bhalla FACC, FSCAI, M.D.	Chief Medical Officer
Mr. Keith Wonnacott	Senior Vice President of Regulatory Affairs
Ms. Ashley Kaplowitz	Head of Capital Markets
Mr. Ryan McHenry	VP & Corporate Controller
Mr. R. Nolan Townsend M.B.A.	CEO & Director
Mr. Louis Tamayo	CFO & Principal Accounting Officer
Dr. Ronald G. Crystal M.D.	Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory Board
Dr. Jose Manuel Otero Ph.D.	Chief Operating Officer

FAQs

What is Lexeo Therapeutics, Inc. share price today?

Lexeo Therapeutics, Inc. share price today is $3.45 as on September 30, 2026 at 9:40 pm IST. Lexeo Therapeutics, Inc. share today touched a day high of $3.59 and a low of $3.33.

What is the 52 week high and 52 week low for Lexeo Therapeutics, Inc. share?

Lexeo Therapeutics, Inc. share touched a 52 week high of $10.99 on December 23, 2025 and a 52 week low of $2.98 on September 29, 2026. Lexeo Therapeutics, Inc. stock price today i.e. September 30, 2026 at 9:40 pm IST is trending at $3.45,which is 68.61% down from its 52 week high and 15.77% up from its 52 week low.

What is Lexeo Therapeutics, Inc.'s market capitalisation today?

Lexeo Therapeutics, Inc. market capitalisation is $0.00T as on September 30, 2026 at 9:40 pm IST.

How to invest in Lexeo Therapeutics, Inc. Stock (LXEO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lexeo Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Lexeo Therapeutics, Inc. Stock (LXEO) from India?

Indian investors can start investing in Lexeo Therapeutics, Inc. (LXEO) shares with as little as ₹95.83000183105469 or $1 (as of September 30, 2026 at 9:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Lexeo Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 30, 2026 at 9:41 pm IST). Based on Lexeo Therapeutics, Inc. share’s latest price of $3.45 as on September 30, 2026 at 9:40 pm IST, you will get 2.8986 shares of Lexeo Therapeutics, Inc.. Learn more about fractional shares .